Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sweeney

Showing results (611-620 of 762) with videos related to

Pageof 77
Sort By:
JAMA Oncology|February 14, 2020
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate CancerJason W D Hearn, Christopher J Sweeney, Nima Almassi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2018
Low Tristetraprolin Expression Is Associated with Lethal Prostate CancerTravis Gerke, Himisha Beltran, Xiaodong Wang, et al.
Urologic Oncology|May 21, 2015
Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imagingVinayak Muralidhar, Kathryn T Dinh, Brandon A Mahal, et al.
The American Journal of Medicine|March 21, 2018
Increased Vulnerability to Poorer Cancer-Specific Outcomes Following Recent DivorceKathryn T Dinh, Ayal A Aizer, Vinayak Muralidhar, et al.
Clinical Genitourinary Cancer|May 3, 2017
Disparities in the Receipt of Local Treatment of Node-positive Prostate CancerVinayak Muralidhar, Brandon A Mahal, Brent S Rose, et al.
The Journal of Bone and Joint Surgery. American Volume|November 8, 2014
Improving residency training in arthroscopic knee surgery with use of a virtual-reality simulator. A randomized blinded studyW Dilworth Cannon, William E Garrett, Robert E Hunter, et al.
Cancer Research|March 27, 2015
PLZF, a tumor suppressor genetically lost in metastatic castration-resistant prostate cancer, is a mediator of resistance to androgen deprivation therapyChen-Lin Hsieh, Ginevra Botta, Shuai Gao, et al.
BJU International|August 4, 2015
Association between very small tumour size and increased cancer-specific mortality after radical prostatectomy in lymph node-positive prostate cancerVinayak Muralidhar, Brandon A Mahal, Michelle D Nezolosky, et al.
Urologic Oncology|October 13, 2014
Income inequality and treatment of African American men with high-risk prostate cancerDavid R Ziehr, Brandon A Mahal, Ayal A Aizer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2023
Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancerW Xie, P Ravi, M Buyse, et al.
Pageof 77

Showing results (611-620 of 762) with videos related to

Sort By:
Pageof 77
JAMA Oncology|February 14, 2020
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate CancerJason W D Hearn, Christopher J Sweeney, Nima Almassi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2018
Low Tristetraprolin Expression Is Associated with Lethal Prostate CancerTravis Gerke, Himisha Beltran, Xiaodong Wang, et al.
Urologic Oncology|May 21, 2015
Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imagingVinayak Muralidhar, Kathryn T Dinh, Brandon A Mahal, et al.
The American Journal of Medicine|March 21, 2018
Increased Vulnerability to Poorer Cancer-Specific Outcomes Following Recent DivorceKathryn T Dinh, Ayal A Aizer, Vinayak Muralidhar, et al.
Clinical Genitourinary Cancer|May 3, 2017
Disparities in the Receipt of Local Treatment of Node-positive Prostate CancerVinayak Muralidhar, Brandon A Mahal, Brent S Rose, et al.
The Journal of Bone and Joint Surgery. American Volume|November 8, 2014
Improving residency training in arthroscopic knee surgery with use of a virtual-reality simulator. A randomized blinded studyW Dilworth Cannon, William E Garrett, Robert E Hunter, et al.
Cancer Research|March 27, 2015
PLZF, a tumor suppressor genetically lost in metastatic castration-resistant prostate cancer, is a mediator of resistance to androgen deprivation therapyChen-Lin Hsieh, Ginevra Botta, Shuai Gao, et al.
BJU International|August 4, 2015
Association between very small tumour size and increased cancer-specific mortality after radical prostatectomy in lymph node-positive prostate cancerVinayak Muralidhar, Brandon A Mahal, Michelle D Nezolosky, et al.
Urologic Oncology|October 13, 2014
Income inequality and treatment of African American men with high-risk prostate cancerDavid R Ziehr, Brandon A Mahal, Ayal A Aizer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2023
Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancerW Xie, P Ravi, M Buyse, et al.
Pageof 77